Petri

GALY Inc. is a biotechnology company founded in 2019, based in the United States, that specializes in the production of cotton through cellular methods rather than traditional agricultural practices. Utilizing proprietary biomaterial technology, GALY cultivates cotton in a laboratory setting, allowing for the creation of high-quality cotton yarns that serve the textile industry. This innovative approach not only offers a cost-effective alternative to conventional cotton but also significantly reduces the environmental impact associated with traditional cotton farming. By providing sustainable raw materials, GALY aims to support clothing brands and textile manufacturers in meeting the growing demand for environmentally friendly fabrics.

Modern Synthesis is a biomaterials company focused on developing sustainable, biobased textiles for the fashion industry. By harnessing the capabilities of bacteria, the company creates customizable bio-textiles and composites that serve as eco-friendly alternatives to traditional materials. Their innovative approach utilizes bacterial nanocellulose, recognized for its strength and versatility, to produce textiles that do not rely on petrochemical binders or harmful chemicals. This process allows for the creation of a wide range of aesthetics and functionalities, meeting the diverse needs of designers while eliminating animal inputs. Modern Synthesis is positioned to transform the fashion industry by providing scalable solutions that integrate seamlessly with existing manufacturing practices, thereby reducing reliance on nonrenewable resources and promoting sustainable material usage.

Minus is a beanless coffee company which produces coffee.

New Equilibrium Biosciences is a biotechnology company focused on developing therapeutic drugs for cancer, neurodegeneration, and other diseases. The company specializes in researching and developing therapeutics that target intrinsically disordered proteins (IDPs) implicated in neurodegenerative disorders. By leveraging artificial intelligence-powered quantum chemistry-based biophysical experiments and IDP-specific compound libraries, New Equilibrium Biosciences identifies transient binding pockets on IDPs to discover lead drug candidates. This approach aims to improve medical procedures by revealing opportunities for structure-based design through advanced biophysics learning with AI.

Yard Stick is a company focused on advancing soil carbon measurement to support climate-friendly agricultural practices. By developing a handheld device that utilizes VisNIR spectrometry, Yard Stick enables real-time evaluation of carbon stocks and changes in soil. This innovative technology significantly reduces the cost of soil carbon measurement by over 90%, addressing previous challenges in the field. The company's solutions empower both scientists and farmers to adopt evidence-based regenerative practices that enhance soil health, boost farmer income, and contribute to the fight against climate change. By facilitating more efficient measurement of soil carbon, Yard Stick aims to expand the adoption of sustainable agricultural methods on a large scale.

Medsix is a medical technology company focused on enhancing patient outcomes through innovative wound drainage solutions. The company has developed a disposable sensor that can be attached to any wound drain, automating the monitoring of drain output with predictive analytics. This technology addresses the challenges associated with current manual monitoring practices, which often lead to inaccuracies in data collection and delayed detection of complications such as infections or blockages. By providing real-time insights, Medsix's sensor aims to facilitate earlier removal of drains, reduce recovery time, and improve overall clinical workflows for healthcare providers. Additionally, the solution is designed to benefit payers by decreasing hospital lengths of stay and readmission rates, ultimately enhancing reimbursement opportunities.

GALY Inc. is a biotechnology company founded in 2019, based in the United States, that specializes in the production of cotton through cellular methods rather than traditional agricultural practices. Utilizing proprietary biomaterial technology, GALY cultivates cotton in a laboratory setting, allowing for the creation of high-quality cotton yarns that serve the textile industry. This innovative approach not only offers a cost-effective alternative to conventional cotton but also significantly reduces the environmental impact associated with traditional cotton farming. By providing sustainable raw materials, GALY aims to support clothing brands and textile manufacturers in meeting the growing demand for environmentally friendly fabrics.

Matterworks is a developer of an artificial intelligence platform focused on advancing the field of metabolomics within the life sciences. The company's technology enhances analytical capabilities, allowing scientific researchers to conduct faster and more comprehensive metabolomic screenings. By facilitating the discovery and engineering processes, Matterworks aims to accelerate scientific progress and support innovation in various biological applications.

New Equilibrium Biosciences is a biotechnology company focused on developing therapeutic drugs for cancer, neurodegeneration, and other diseases. The company specializes in researching and developing therapeutics that target intrinsically disordered proteins (IDPs) implicated in neurodegenerative disorders. By leveraging artificial intelligence-powered quantum chemistry-based biophysical experiments and IDP-specific compound libraries, New Equilibrium Biosciences identifies transient binding pockets on IDPs to discover lead drug candidates. This approach aims to improve medical procedures by revealing opportunities for structure-based design through advanced biophysics learning with AI.